VivoSeq
Other

Labor

0

Pipeline Programs↗

6

Active Trials↗

3

Companies Involved↗

Labor is an early-stage landscape with 0 programs across 3 companies. The most active players are Fresenius Kabi USA, LLC, Insud Pharma, Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

F

Fresenius Kabi USA, LLC

0 programs

PreclinicalI

Insud Pharma

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

53

clinical trials

Completed31 · 58%
Unknown status11 · 21%
Recruiting4 · 8%
Withdrawn3 · 6%
Suspended1 · 2%
Not yet recruiting1 · 2%
Other2 · 4%

Clinical Trials

Trial Activity

53 trials

Calcium Carbonate to Augment Labor Contractions
Recruiting·WWeill Medical College of Cornell University·Phase 4·NCT06580782·60 enrolled
Management of Prelabor Rupture of the Membranes at Term
Recruiting·RRambam Health Care Campus·N/A·NCT04307069·524 enrolled
Prospective Observation Study of Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients
Recruiting·BBrigham and Women's Hospital·N/A·NCT02193542·400 enrolled
Development of a Multidimensional Predictive Model of Dystocic Labor (MPM-PD): Pilot Study on the Association of Physical Condition and Psychosocial Factors With the Completion of Labor and the Success of Breastfeeding.
Recruiting·IInstitut Investigacio Sanitaria Pere Virgili·N/A·NCT07635771·420 enrolled
Collaborative Urological Prosthetics Investigation Directive Research Group
Active, not recruiting·UUniversity of Chicago·Phase 1·NCT05100654·800 enrolled
45th Multicenter Airway Research Collaboration
Not yet recruiting·MMassachusetts General Hospital·Phase 4·NCT07166939·1,860 enrolled
Oral Calcium Supplementation in Labor
Completed·—·Phase 2/3·NCT07056062·89 enrolled
Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition
Completed·—·Phase 1·NCT01133444·24 enrolled
Hyoscine Butylbromide Effect on Duration of Labor
Completed·SSaint Thomas Hospital, Panama·N/A·NCT03441217·218 enrolled
Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
Completed·—·Phase 1·NCT01159158·68 enrolled
Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition
Completed·—·Phase 1·NCT01052909·44 enrolled
Maraviroc Switch Collaborative Study
Completed·KKirby Institute·Phase 4·NCT01384682·399 enrolled
Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions
Completed·—·Phase 1·NCT01066767·30 enrolled
Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
Completed·FFresenius Kabi USA, LLC·Phase 1·NCT02086227·32 enrolled
Safety Study of Hyoscine N Butyl Bromide in Active Management of Labor
Completed·SSisli Hamidiye Etfal Training and Research Hospital·Phase 4·NCT02098889·382 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)